Riociguat rEplacing PDE-5i Therapy evaLuated Against Continued PDE-5i thErapy
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Bayer
Related studies linked through entity extraction aliases.
Sun Protection Factor Assay (SPF Assay 104/2016)
- Status
- COMPLETED
- Phase
- NA
Sun Protection Factor Assay (SPF Assay 105/2016)
- Status
- COMPLETED
- Phase
- NA
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Case-control
- Status
- COMPLETED
- Phase
- N/A
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases: Inception Cohort
- Status
- COMPLETED
- Phase
- N/A
Molecular Reclassification to Find Clinically Useful Biomarkers for Systemic Autoimmune Diseases:
- Status
- COMPLETED
- Phase
- N/A
Sun Protection Factor (SPF) Efficacy Assay
- Status
- COMPLETED
- Phase
- NA
Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept
- Status
- COMPLETED
- Phase
- N/A
Supervised Outdoor-Use Test For Sunscreen Products in Adults
- Status
- COMPLETED
- Phase
- NA
Xarelto Evidence in Real Life of Patients' Preference and Satisfaction Study
- Status
- COMPLETED
- Phase
- N/A
A Digital Non-interventional Atrial Fibrillation (AF) Screening Study With Commercial Pulse Detection Systems
- Status
- COMPLETED
- Phase
- N/A
Intravitreal Aflibercept InjectiOn in Vitrectomized Eyes for Treatment of Diabetic Macular Edema
- Status
- COMPLETED
- Phase
- N/A
Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) - Assay
- Status
- COMPLETED
- Phase
- NA
Sun Protection Factor (SPF) / UVA Protection Factor (UVAPF) Assay
- Status
- COMPLETED
- Phase
- NA
To Test for Photo Allergy Reaction of Sunscreens
- Status
- COMPLETED
- Phase
- NA
Evaluation of the Stinging Potential in Human Eyes
- Status
- COMPLETED
- Phase
- NA
Evaluation of the Stinging Potential of Products in Human Eyes
- Status
- COMPLETED
- Phase
- NA
Evaluation of the Stinging Potential of Sunscreen Products in Human Eyes
- Status
- COMPLETED
- Phase
- NA
Evaluation of the Pharmacokinetics and Safety of BAY3427080 (NT-814) in Post-Menopausal Women With Vasomotor Symptoms
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Benefit-Risk Of Arterial THrombotic prEvention With Rivaroxaban for Atrial Fibrillation in France
- Status
- COMPLETED
- Phase
- N/A